Of the 11 321 individuals with GDM who initiated glyburide or insulin during pregnancy (mean [SD] age, 32.9 [4.9] years), 10 249 (91%) used glyburide as the initial medication therapy, and 1072 (9%) used insulin as the initial medication therapy. This evidence concerns the gene INS and gestational diabetes.